Saturday, Jun 20, 2026
Breaking
Search
Home
Business
Entertainment
News
Sports
Tech
World
Explore by Topics
Subscribe
Search
Business
Entertainment
News
Sports
Tech
World
Subscribe Newsletter
Daily Stories
Stock Alerts
Full Access
Subscribe to our newsletter to get our newest articles instantly!
I have read and agree to the terms & conditions
Merck
Business
Merck, Eisai Update Phase 3 Trial on Advanced Renal Cancer Treatments
April 21, 2026
Business
Merck’s Keytruda: Bridging Global Health Disparities
April 13, 2026
Business
Merck Acquires Terns for $6.7B, Targets Leukemia Drug to Rival Novartis
March 26, 2026
Business
Terns Pharmaceuticals and Merck: Deal Talk Emerges as 2025 Approaches
March 25, 2026
News
Merck Launches New Cancer Unit to Counter Keytruda Revenue Decline
February 24, 2026
Business
Moderna and Merck: mRNA Cancer Vaccine Effective After 5 Years
January 22, 2026
Business
Merck Finalizes Acquisition of Cidara Therapeutics
January 7, 2026
News
Merck and U.S. Government Agree to Expand Medicine Access, Lower Costs
December 20, 2025
Business
Cidara Therapeutics Secures $9.2 Billion Merck Buyout; Shares Soar
November 15, 2025
Business
Merck Acquires Cidara Therapeutics, Expands Portfolio with Late-Phase Antiviral Agent
November 14, 2025
Business
Merck Acquires Cidara Therapeutics, Expands Portfolio with Antiviral Innovations
November 14, 2025
Business
Merck’s Oral PCSK9 Inhibitor Cuts LDL-C in Phase 3 Trial
November 9, 2025
Show More
Loading...
